Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$161.52+0.73 (+0.45%)
Close on Nov 2, 2026Market cap $308.21BP/E 22.6Yield –
Novartis US Policy Lobbying Expenditures by Year
US Policy Lobbying Expenditures (USD millions) ($M)
Novartis US Policy Lobbying Expenditures: $5.17M in FY2025, up 13.8% from a year earlier.
Latest, FY2025
5.17
Period ended Dec 31, 2025
Change on a year earlier
+13.8%
4.54 in FY2024
History
2 years
Since FY2024
Sources
1
Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf
Where the FY2025 figure comes from
“| US | 5 166 | 4 538 | 41”
Source: Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗
Reported in ESG Data Summary 2025.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | US Policy Lobbying Expenditures (USD millions) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5.17 | +13.8% | Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗ |
| FY2024 | Dec 31, 2024 | 4.54 | – | Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗ |
Cite this data
StockData. (2026). Novartis US Policy Lobbying Expenditures ($M), annual FY2024–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/gov-lobbying-us-m
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.